May 20, 2020 / 02:50PM GMT
Navin Cyriac Jacob - UBS Investment Bank, Research Division - Equity Research Analyst of Specialty Pharmaceuticals and Large Cap Pharmaceutic
Hello, and welcome to day 3 of the UBS Healthcare Conference. My name is Navin Jacob, senior analyst covering large-cap pharmaceuticals and smid-cap biotech. Our next presentation and fireside chat is with AbbVie. I'm very happy to have with me Mike Severino, Vice Chairman and President of AbbVie; as well as Rob Michael, CFO of AbbVie; as well as Liz Shea, Head of Investor Relations. Thank you all for joining us today.
Robert A. Michael - AbbVie Inc. - Executive VP & CFO
Thanks for having us.
Navin Cyriac Jacob - UBS Investment Bank, Research Division - Equity Research Analyst of Specialty Pharmaceuticals and Large Cap Pharmaceutic
Pleasure.
Questions and Answers:
Navin Cyriac Jacob - UBS Investment Bank, Research Division - Equity Research Analyst of Specialty Pharmaceuticals and Large Cap PharmaceuticWe are just going to